Differential methylation of the TRPA1 promoter in pain sensitivity

Jordana T. Bell(Centre for Human Genetics), A. Katrina Loomis(Pfizer (United States)), Lee M Butcher(University College London), Fei Gao(BGI Group (China)), Baohong Zhang(Pfizer (United States)), Craig Hyde(Pfizer (United States)), Jihua Sun(BGI Group (China)), Honglong Wu(BGI Group (China)), Kirsten Ward(King's College London), Juliette Harris(King's College London), Serena Scollen(Pfizer (United Kingdom)), Matthew N Davies(King's College London), Leonard C. Schalkwyk(King's College London), Jonathan Mill(King's College London), Kourosh R. Ahmadi(King's College London), Chrysanthi Ainali(King's College London), Amy Barrett(Churchill Hospital), Véronique Bataille(King's College London), Jordana T. Bell(Centre for Human Genetics), Alfonso Buil(University of Geneva), Panos Deloukas(Queen Mary University of London), Emmanoil T. Dermitzakis(University of Geneva), Antigone S. Dimas(University of Geneva), Richard Durbin(Wellcome Sanger Institute), Daniel Glass(King's College London), Elin Grundberg(King's College London), Neelam Hassanali(Churchill Hospital), Åsa K. Hedman(Centre for Human Genetics), Catherine Ingle(Wellcome Sanger Institute), David A. Knowles(University of Cambridge), Maria Krestyaninova(European Bioinformatics Institute), Cecilia M. Lindgren(Centre for Human Genetics), Christopher Lowe(University of Cambridge), Mark I. McCarthy(Centre for Human Genetics), Eshwar Meduri(King's College London), Paola Di Meglio(King's College London), Josine L. Min(Centre for Human Genetics), Stephen B. Montgomery(University of Geneva), Frank O. Nestlé(King's College London), Alexandra C. Nica(University of Geneva), James Nisbet(Wellcome Sanger Institute), Stephen O’Rahilly(University of Cambridge), Leopold Parts(Wellcome Sanger Institute), Simon Potter(Wellcome Sanger Institute), Magdalena Sekowska(Wellcome Sanger Institute), So–Youn Shin(Wellcome Sanger Institute), Kerrin S. Small(King's College London), Nicole Soranzo(Wellcome Sanger Institute), Tim D. Spector(King's College London), Gabriela Surdulescu(King's College London), Mary E. Travers(Churchill Hospital), Loukia Tsaprouni(Wellcome Sanger Institute), Sophia Tsoka(King's College London), Alicja Wilk(Pfizer (United Kingdom)), Tsun-Po Yang(Wellcome Sanger Institute), Krina T. Zondervan(Centre for Human Genetics), Frances M. K. Williams(King's College London), Nailin Li(BGI Group (China)), Panos Deloukas(Queen Mary University of London), Stephan Beck(University College London), Stephen B. McMahon(King's College London), Jian Wang(BGI Group (China)), Sajo John(Pfizer (United States)), Tim D. Spector(King's College London)
Nature Communications
February 4, 2014
Cited by 153Open Access
Full Text

Abstract

Chronic pain is a global public health problem, but the underlying molecular mechanisms are not fully understood. Here we examine genome-wide DNA methylation, first in 50 identical twins discordant for heat pain sensitivity and then in 50 further unrelated individuals. Whole-blood DNA methylation was characterized at 5.2 million loci by MeDIP sequencing and assessed longitudinally to identify differentially methylated regions associated with high or low pain sensitivity (pain DMRs). Nine meta-analysis pain DMRs show robust evidence for association (false discovery rate 5%) with the strongest signal in the pain gene TRPA1 (P=1.2 × 10(-13)). Several pain DMRs show longitudinal stability consistent with susceptibility effects, have similar methylation levels in the brain and altered expression in the skin. Our approach identifies epigenetic changes in both novel and established candidate genes that provide molecular insights into pain and may generalize to other complex traits.


Related Papers

No related papers found

Powered by citation graph analysis